Literature DB >> 7598503

Polyamine regulation of N-methyl-D-aspartate receptor channels.

D M Rock1, R L Macdonald.   

Abstract

Endogenous polyamines such as spermine and spermidine have multiple effects in the central nervous system and have been suggested to be neurotransmitters or neuromodulators. One effect of the polyamines is to regulate the activity of the N-methyl-D-aspartate receptor (NMDAR) channel subtype of glutamate receptor channels. The effects of polyamines on NMDAR currents are complex, suggesting the presence of one or more polyamine-binding sites on the receptor channel. Electrophysiological studies have shown that polyamines enhance NMDAR currents by increasing channel opening frequency and by increasing the affinity of the receptor for glycine. Polyamines have been shown to reduce NMDAR currents by producing voltage-dependent reduction of single-channel amplitudes and/or by producing an open channel block. Recent molecular biological studies have shown that the polyamine effects on NMDAR channels involve interactions with multiple NMDAR subunits and are characterizing the structural basis for the polyamine regulation of NMDAT receptor channels.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7598503     DOI: 10.1146/annurev.pa.35.040195.002335

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN: 0362-1642            Impact factor:   13.820


  30 in total

Review 1.  Glucocorticoid and polyamine interactions in the plasticity of glutamatergic synapses that contribute to ethanol-associated dependence and neuronal injury.

Authors:  Mark A Prendergast; Patrick J Mulholland
Journal:  Addict Biol       Date:  2011-10-04       Impact factor: 4.280

2.  Evidence of altered polyamine concentrations in cerebral cortex of suicide completers.

Authors:  Gary Gang Chen; Laura M Fiori; Luc Moquin; Alain Gratton; Orval Mamer; Naguib Mechawar; Gustavo Turecki
Journal:  Neuropsychopharmacology       Date:  2010-03-03       Impact factor: 7.853

Review 3.  Allosteric modulators of NR2B-containing NMDA receptors: molecular mechanisms and therapeutic potential.

Authors:  Laetitia Mony; James N C Kew; Martin J Gunthorpe; Pierre Paoletti
Journal:  Br J Pharmacol       Date:  2009-07-08       Impact factor: 8.739

Review 4.  Targets of polyamine dysregulation in major depression and suicide: Activity-dependent feedback, excitability, and neurotransmission.

Authors:  Agenor Limon; Firoza Mamdani; Brooke E Hjelm; Marquis P Vawter; Adolfo Sequeira
Journal:  Neurosci Biobehav Rev       Date:  2016-04-22       Impact factor: 8.989

5.  Inhibition of 5-HT3 receptor function by imidazolines in mouse neuroblastoma cells: potential involvement of sigma 2 binding sites.

Authors:  G J Molderings; K Schmidt; H Bönisch; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996 Aug-Sep       Impact factor: 3.000

6.  Immunoelectron microscopic study of polyamines in the gastrointestinal tract of rat.

Authors:  Masashi Shin; Kae Hirokawa; Kunio Fujiwara
Journal:  Histochem Cell Biol       Date:  2005-10-08       Impact factor: 4.304

Review 7.  Acid-sensing ion channels in pathological conditions.

Authors:  Xiang-Ping Chu; Zhi-Gang Xiong
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

8.  Polyamine transport by the polyspecific organic cation transporters OCT1, OCT2, and OCT3.

Authors:  Monica Sala-Rabanal; Dan C Li; Gregory R Dake; Harley T Kurata; Mikhail Inyushin; Serguei N Skatchkov; Colin G Nichols
Journal:  Mol Pharm       Date:  2013-03-19       Impact factor: 4.939

9.  Agmatine reduces ultrasonic vocalization deficits in female rat pups exposed neonatally to ethanol.

Authors:  Kristen Wellmann; Ben Lewis; Susan Barron
Journal:  Neurotoxicol Teratol       Date:  2009-11-27       Impact factor: 3.763

10.  Modification of [3H]MK801 binding to rat brain NMDA receptors after the administration of a convulsant drug and an adenosine analogue: a quantitative autoradiographic study.

Authors:  L Giraldez; E Girardi
Journal:  Neurochem Res       Date:  1998-10       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.